Tina Marriott - 14 Feb 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role: President and COO
Signature: /s/ Nathan Hatfield, attorney-in-fact
Issuer symbol: RXRX
Transactions as of: 14 Feb 2022
Net transactions value: +$4,240
Form type: 4
Filing time: 17 Feb 2022, 05:04:38 UTC
Previous filing: 08 Feb 2022
Next filing: 22 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RXRX	Class A Common Stock	Options Exercise	$4,240	+4,000	+3.1%	$1.06^*	133,518	14 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RXRX	Stock Option (Right to Buy)	Options Exercise	$0	+4,000	+0.57%	$0.000000	708,500	14 Feb 2022	Class A Common Stock	708,500	$1.06	Direct	F1
holding	RXRX	Stock Option (Right to Buy)						159,226	14 Feb 2022	Class A Common Stock	159,226	$11.40	Direct	F2
holding	RXRX	Stock Option (Right to Buy)						4,784	14 Feb 2022	Class A Common Stock	4,784	$11.40	Direct
holding	RXRX	Stock Option (Right to Buy)						150,000	14 Feb 2022	Class A Common Stock	150,000	$2.47	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date.
F2	The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F3	One forty-eighth (1/48th) of the shares subject to the award shall vest one month after December 31, 2020, or the Monthly Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Monthly Vesting Commencement Date.